BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16258113)

  • 1. Therapy-related myelodysplastic syndrome and acute myeloid leukemia after autologous bone marrow transplantation: dosis facit venenum?
    Sill H; Olipitz W; Schimek MG
    J Clin Oncol; 2005 Nov; 23(31):8120-1; author reply 8121-2. PubMed ID: 16258113
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
    J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of therapy-related leukemia and myelodysplastic syndrome.
    Kantarjian HM; Estey EH; Keating MJ
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):81-107. PubMed ID: 7680643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy-related acute leukaemia and myelodysplastic syndrome].
    Díaz Beveridge R; Aparicio Urtasun J
    An Med Interna; 2003 May; 20(5):257-68. PubMed ID: 12831302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
    Metayer C; Curtis RE; Vose J; Sobocinski KA; Horowitz MM; Bhatia S; Fay JW; Freytes CO; Goldstein SC; Herzig RH; Keating A; Miller CB; Nevill TJ; Pecora AL; Rizzo JD; Williams SF; Li CY; Travis LB; Weisdorf DJ
    Blood; 2003 Mar; 101(5):2015-23. PubMed ID: 12393427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.
    Fassas AB; Tricot G
    Cancer Treat Res; 2001; 108():169-84. PubMed ID: 11702599
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
    Hallemeier CL; Girgis MD; Blum WG; Brown RA; Khoury HJ; Devine SM; Vij R; Lin HS; DiPersio JF; Adkins DR
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):749-57. PubMed ID: 16785064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary myelodysplastic syndromes and acute leukemias.
    Zeidman A; Dayan DB; Mittelman M
    Haematologia (Budap); 1995; 27(1):23-8. PubMed ID: 12051292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
    Kröger N; Brand R; van Biezen A; Cahn JY; Slavin S; Blaise D; Sierra J; Zander A; Niederwieser D; de Witte T;
    Bone Marrow Transplant; 2006 Jan; 37(2):183-9. PubMed ID: 16299545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary myelodysplastic syndrome].
    Shammas FV; Heikkilä R
    Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4220-2. PubMed ID: 9441464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia].
    Takahashi R; Shimazaki C; Inaba T; Nakagawa M; Yamaoka M
    Rinsho Ketsueki; 2002 Oct; 43(10):963-5. PubMed ID: 12462035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-dose cyclophosphamide and whole-body radiotherapy followed by bone marrow transplant in patients with leukemia].
    Fernández-Rañada JM; Vázquez L; Lozano M; Fernández-Garese D; Figuera A; Arranz R; González N; Gómez N; Fernández Villalta MJ; Gómez-Reino F
    Rev Clin Esp; 1987 Mar; 180(5):247-52. PubMed ID: 3299537
    [No Abstract]   [Full Text] [Related]  

  • 13. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloid leukemia.
    Muroi K; Kawano C; Yokote T; Otsuki T; Kirito K; Komatsu N; Ozawa K
    Leuk Lymphoma; 2002 Jul; 43(7):1493-6. PubMed ID: 12389635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
    Friedberg JW
    Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
    Alyea EP; Kim HT; Ho V; Cutler C; DeAngelo DJ; Stone R; Ritz J; Antin JH; Soiffer RJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1047-55. PubMed ID: 17067911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary leukaemia after autologous bone marrow transplantation.
    Kumar L
    Lancet; 1995 Apr; 345(8953):810. PubMed ID: 7898226
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bone marrow transplantation in leukemia].
    Tomas ED
    Ter Arkh; 1983; 55(8):15-9. PubMed ID: 6356435
    [No Abstract]   [Full Text] [Related]  

  • 19. Myeloid leukemia after cytotoxic therapy and other hematotoxins.
    Larson RA
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):381-6. PubMed ID: 11086943
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies.
    Ringdén O; Ruutu T; Remberger M; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Ljungman P
    Transplant Proc; 1994 Jun; 26(3):1831-2. PubMed ID: 8030160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.